Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre

Selvapatt N, Ward T, Bailey H, et al. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre. Bennett H, Thorne C, See L-M, Tudor-Williams G, Thursz M, McEwan P, et al. J Hepatology. 2015;63(4):797-804.

Publication Type:

Journal Article

Authors:

Selvapatt, Nowlan; Ward, Thomas; Bailey, Heather; et, al

Source:

J Hepatology, Volume 63, Issue 4, p.797-804 (2015)

Keywords:

Adult, Antenatal, Cost-Benefit Analysis, cost-effectiveness, Feasibility Studies, Female, Hepacivirus, Hepatitis C, Humans, Incidence, London, Middle Aged, MONARCH, Pregnancy, Pregnancy Complications, Infectious, Prenatal Diagnosis, Retrospective Studies, Screening, Young Adult

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/26024832

Export Citation:
RIS Format
Top